Norol F - Search Results

1

Dexamethasone, high-dose cytarabine, and oxaliplatin (DHAOx) as salvage treatment for patients with initially refractory or relapsed non-Hodgkin's lymphoma.

Machover D, Delmas-Marsalet B, Misra SC, Gumus Y, Goldschmidt E, Schilf A, Frénoy N, Emile JF, Debuire B, Guettier C, Farrokhi P, Boulefdaoui B, Norol F, Parquet N, Ulusakarya A, Jasmin C. Machover D, et al. Among authors: norol f. Ann Oncol. 2001 Oct;12(10):1439-43. doi: 10.1023/a:1012501305214. Ann Oncol. 2001. PMID: 11762817 Free article. Clinical Trial.

2

Comparison of autografting using mobilized peripheral blood stem cells with and without granulocyte colony-stimulating factor in malignant lymphomas.

Brice P, Divine M, Marolleau JP, Haioun C, Dalcortivo L, Sitthy X, Beaujean F, Norol F, Benbunan M, Reyes F, et al. Brice P, et al. Among authors: norol f. Bone Marrow Transplant. 1994 Jul;14(1):51-5. Bone Marrow Transplant. 1994. PMID: 7524907 Clinical Trial.

3

High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease.

Gabarre J, Marcelin AG, Azar N, Choquet S, Lévy V, Lévy Y, Tubiana R, Charlotte F, Norol F, Calvez V, Spina M, Vernant JP, Autran B, Leblond V. Gabarre J, et al. Among authors: norol f. Haematologica. 2004 Sep;89(9):1100-8. Haematologica. 2004. PMID: 15377471

4

Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: hematologic recovery and costs. A randomized, controlled trial.

Hartmann O, Le Corroller AG, Blaise D, Michon J, Philip I, Norol F, Janvier M, Pico JL, Baranzelli MC, Rubie H, Coze C, Pinna A, Méresse V, Benhamou E. Hartmann O, et al. Among authors: norol f. Ann Intern Med. 1997 Apr 15;126(8):600-7. doi: 10.7326/0003-4819-126-8-199704150-00002. Ann Intern Med. 1997. PMID: 9103126 Clinical Trial.

5

Absence of graft-versus-leukemia (GVL) effect by leucocytes transfused: a prospective randomized trial in acute myeloid leukemia (AML) patients.

Norol F, Parquet N, Kuentz M, Bierling P, Cordonnier C, Beaujean F, Duedari N, Vernant JP. Norol F, et al. Br J Haematol. 1991 Aug;78(4):591-3. doi: 10.1111/j.1365-2141.1991.tb04509.x. Br J Haematol. 1991. PMID: 1911364 Clinical Trial. No abstract available.

6

Delayed recovery after autologous peripheral hematopoietic cell transplantation: potential effect of a high number of total nucleated cells in the graft.

Trébéden-Negre H, Rosenzwajg M, Tanguy ML, Lefrere F, Azar N, Heshmati F, Belhocine R, Vernant JP, Klatzmann D, Norol F. Trébéden-Negre H, et al. Among authors: norol f. Transfusion. 2010 Dec;50(12):2649-59. doi: 10.1111/j.1537-2995.2010.02746.x. Transfusion. 2010. PMID: 20576009

7

Infusion of allogeneic natural killer cells in a patient with acute myeloid leukemia in relapse after haploidentical hematopoietic stem cell transplantation.

Nguyen S, Béziat V, Norol F, Uzunov M, Trebeden-Negre H, Azar N, Boudifa A, Bories D, Debré P, Vernant JP, Vieillard V, Dhédin N. Nguyen S, et al. Among authors: norol f. Transfusion. 2011 Aug;51(8):1769-78. doi: 10.1111/j.1537-2995.2010.03058.x. Epub 2011 Feb 18. Transfusion. 2011. PMID: 21332732

8

A clinical trial combining megakaryocytes and haematopoietic stem cells to promote engraftment after autologous transplantation.

Trebeden-Negre H, Choquet S, Tanguy ML, Rozenzwajg M, Azar N, Lefrère F, Heshmati F, Belhocine R, Vieillard V, Norol F. Trebeden-Negre H, et al. Among authors: norol f. Br J Haematol. 2018 Oct;183(1):139-142. doi: 10.1111/bjh.14911. Epub 2017 Sep 10. Br J Haematol. 2018. PMID: 28891211 Free article. Clinical Trial. No abstract available.

9

GFP-transduced CD34+ and Lin- CD34- hematopoietic stem cells did not adopt a cardiac phenotype in a nonhuman primate model of myocardial infarct.

Norol F, Bonnet N, Peinnequin A, Chretien F, Legrand R, Isnard R, Herodin F, Baillou C, Delache B, Negre D, Klatzmann D, Vernant JP, Lemoine FM. Norol F, et al. Exp Hematol. 2007 Apr;35(4):653-61. doi: 10.1016/j.exphem.2006.12.003. Exp Hematol. 2007. PMID: 17379075 Free article.

10

Regulatory T cell content in the bone marrow graft does not predict the occurrence of acute GVHD.

Rosenzwajg M, Dhédin N, Maury S, Bensimon G, Landau DA, Norol F, Trébéden-Negre H, Uzunov M, Vernant JP, Klatzmann D, Cohen JL. Rosenzwajg M, et al. Among authors: norol f. Biol Blood Marrow Transplant. 2011 Feb;17(2):265-9. doi: 10.1016/j.bbmt.2010.07.024. Epub 2010 Aug 5. Biol Blood Marrow Transplant. 2011. PMID: 20691799 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters